Clinical trial
Vision II: Evaluation of GALILEO Intravascular Radiotherapy System
NCT00180583 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00180583 |
|---|---|
| Title | Vision II: Evaluation of GALILEO Intravascular Radiotherapy System |
| Official title | Vision II: Non Randomized French Evaluation of GALILEO Intravascular Radiotherapy System in Patients With de Novo Coronary Arteries Lesions by Restenosis on Angioplasty or Restenosis on Endoprosthesis |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | Guidant GALILEO Intravascular Radiotherapy System |
| Enrollment | 268 |
| Start date | Feb 1, 2002 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Aug 1, 2008 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: